Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Varicella zoster virus vaccine - Changchun BCHT Biotechnology

Next Previous
X
Search
Drug Profile

Varicella zoster virus vaccine - Changchun BCHT Biotechnology

Alternative Names: Shingles Vaccine - Changchun BCHT Biotechnology

Latest Information Update: 16 Dec 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Changchun BCHT Biotechnology
  • Class Varicella vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Varicella zoster virus infections
  • Phase III Herpes zoster

Most Recent Events

  • 18 Jul 2021 Changchun BCHT Biotechnology completes a phase III trial in Herpes zoster (Prevention) in China in July 2021(NCT04334577)
  • 20 Apr 2020 Phase-III clinical trials in Herpes zoster in China (SC) in April 2021 (NCT04334577)
  • 08 Apr 2020 Changchun BCHT Biotechnology plans a phase III trial for Herpes zoster (Prevention, In adults) in China (SC) (NCT04334577)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top